Allianz Asset Management GmbH - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2021$183,000
-56.1%
15,205
-22.8%
0.00%
Q2 2021$417,000
-56.7%
19,705
-42.6%
0.00%
-100.0%
Q1 2021$963,000
+7.8%
34,3450.0%0.00%0.0%
Q4 2020$893,000
-59.6%
34,345
-42.2%
0.00%
-66.7%
Q3 2020$2,209,000
-29.2%
59,425
-2.2%
0.00%
-25.0%
Q2 2020$3,118,000
+117.9%
60,751
+33.8%
0.00%
+100.0%
Q1 2020$1,431,000
-39.9%
45,404
+13.7%
0.00%0.0%
Q4 2019$2,381,000
+90.8%
39,922
+28.5%
0.00%
+100.0%
Q1 2019$1,248,000
-36.7%
31,078
-28.5%
0.00%
-50.0%
Q4 2018$1,972,000
-33.8%
43,467
-35.2%
0.00%
-33.3%
Q3 2018$2,977,000
+13.2%
67,1050.0%0.00%0.0%
Q2 2018$2,630,000
+61.9%
67,105
+198.9%
0.00%
+50.0%
Q1 2018$1,624,000
-32.5%
22,451
-78.0%
0.00%
-33.3%
Q3 2015$2,407,000
-55.1%
102,020
+55.7%
0.00%
-50.0%
Q2 2015$5,359,000
-11.2%
65,540
+0.6%
0.01%
-14.3%
Q1 2015$6,034,000
+331.6%
65,167
+88.5%
0.01%
+250.0%
Q4 2014$1,398,00034,5670.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 2,629,835$116,685,00025.08%
Aviva Holdings Ltd. 1,200,100$53,248,00014.21%
Boxer Capital, LLC 1,375,000$61,009,0006.77%
BB BIOTECH AG 3,282,964$145,665,0003.86%
Rhenman & Partners Asset Management AB 353,961$15,705,0001.57%
PFM Health Sciences, LP 1,970,134$87,415,0001.28%
Bellevue Group AG 391,852$17,386,0001.10%
Pentwater Capital Management LP 2,351,500$104,336,0000.88%
Partner Investment Management, L.P. 25,440$1,129,0000.86%
SABBY MANAGEMENT, LLC 100,369$4,453,0000.57%
View complete list of ESPERION THERAPEUTICS INC NE shareholders